Jing Zhao Ming Zou Jinyan Lv Yingmin Han Guangzhi Wang Gang Wang
10.2147/OTT.S170358
Onco Targets Ther
2018 Sep 6;11:5545-5550.
egfr cis-c797s egfr-t790m drug resistance mechanisms pulmonary adenocarcinoma
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/30233215/
Case Reports
PMC6134962
30233215
Effective treatment of pulmonary adenocarcinoma harboring triple EGFR mutations of L858R, T790M, and cis-C797S by osimertinib, bevacizumab, and brigatinib combination therapy: a case report
2018